Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 77751-77800 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05739071
JING SI HERBAL TEA and Urinary Tract Symptoms in Bladder Cancer
NAEnrolling by invitation
100 participants
Started: Feb 22, 2023 · Completed: Dec 31, 2027
4 conditions1 sponsor1 location
NCT05751967
Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis
PHASE3Recruiting
150 participants
Started: Feb 22, 2023 · Completed: Dec 1, 2025
1 condition1 sponsor7 locations
NCT07045779
Oral Myofunctional Pattern in Children With Anterior Open Bite
NARecruiting
33 participants
Started: Feb 22, 2023 · Completed: May 31, 2026
2 conditions2 sponsors1 location
NCT05651932
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
PHASE1Recruiting
125 participants
Started: Feb 22, 2023 · Completed: Jun 30, 2026
3 conditions2 sponsors21 locations
NCT05883436
Investigation of DEXA-C Anterior Cervical Interbody System
NARecruiting
80 participants
Started: Feb 22, 2023 · Completed: Feb 22, 2027
1 condition1 sponsor4 locations
NCT05648448
A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza
PHASE2Recruiting
3,000 participants
Started: Feb 22, 2023 · Completed: Jan 1, 2027
2 conditions1 sponsor4 locations
NCT05683886
A Study of KC1036 in Patients with Advanced Thymic Tumors
PHASE2Recruiting
30 participants
Started: Feb 22, 2023 · Completed: Feb 28, 2026
1 condition1 sponsor2 locations
NCT06294834
Improving Clinician Capacity to Provide Interventions for Manual Wheelchair Users
NAActive, not recruiting
235 participants
Started: Feb 22, 2023 · Completed: Dec 30, 2026
2 conditions3 sponsors1 location
NCT05687188
Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations
N/ARecruiting
125 participants
Started: Feb 22, 2023 · Completed: Dec 31, 2026
1 condition2 sponsors2 locations
NCT05742386
Impact of Standing Orders Optimization
NAActive, not recruiting
28 participants
Started: Feb 22, 2023 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT05721976
"With Love, Grandma (Con Cariño, Abuelita) Pilot Study"
NARecruiting
60 participants
Started: Feb 22, 2023 · Completed: Mar 1, 2026
6 conditions2 sponsors1 location
NCT05620836
A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa (HS)
PHASE3Active, not recruiting
619 participants
Started: Feb 22, 2023 · Completed: Jan 30, 2026
1 condition1 sponsor101 locations
NCT05762510
A Study Evaluating the Safety and Efficacy of LentiRed Drug Product in Transfusion-dependent β-Thalassemia [TDT]
EARLY_PHASE1Recruiting
5 participants
Started: Feb 22, 2023 · Completed: Oct 31, 2030
1 condition2 sponsors1 location
NCT06286540
"Evaluation of the Efficacy and Safety of Surgical Device Lymphoblock for Prevention of Lymphorrhea in Patients With Thoracoabdominal Aorta Repair."
NARecruiting
138 participants
Started: Feb 22, 2023 · Completed: May 31, 2026
2 conditions1 sponsor1 location
NCT05717985
Evaluation of De-epithelized Connective Tissue Grafts and Modified Combined Approach for Connective Tissue Grafts
NARecruiting
36 participants
Started: Feb 22, 2023 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05857969
Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
PHASE1Recruiting
65 participants
Started: Feb 22, 2023 · Completed: Dec 31, 2028
18 conditions4 sponsors1 location
NCT05800977
A Study of C-CAR039 (Prizloncabtagene Autoleucel) in Patients with Relapsed/Refractory Large B-Cell Lymphoma
PHASE1/PHASE2Recruiting
112 participants
Started: Feb 22, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor15 locations
NCT05952661
Minimally Residual of Esophageal Cancer 001
N/ARecruiting
56 participants
Started: Feb 22, 2023 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT05534516
A Study of Physiologic Changes in a Telemetry Unit
N/AEnrolling by invitation
500 participants
Started: Feb 22, 2023 · Completed: Aug 31, 2027
1 condition1 sponsor1 location
NCT05522387
An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease
PHASE2Active, not recruiting
11 participants
Started: Feb 21, 2023 · Completed: Dec 31, 2024
9 conditions1 sponsor4 locations
NCT05755503
Toxicokinetics of Protein-bound Uremic Toxins in ESRD Patients
N/ARecruiting
100 participants
Started: Feb 21, 2023 · Completed: Dec 30, 2025
3 conditions1 sponsor1 location
NCT05459402
Divided or Single Exposure (DOSE) Study
PHASE2/PHASE3Recruiting
150 participants
Started: Feb 21, 2023 · Completed: Oct 1, 2028
3 conditions2 sponsors1 location
NCT05763563
Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunotherapy
NAActive, not recruiting
20 participants
Started: Feb 21, 2023 · Completed: Jan 19, 2026
3 conditions2 sponsors1 location
NCT06027242
Oral Supplementation of Glutamine on Gastric Cancer Patients After Gastrectomy
NARecruiting
120 participants
Started: Feb 21, 2023 · Completed: Aug 30, 2026
3 conditions1 sponsor1 location
NCT05716087
A Study of Rocbrutinib in Participants with Relapse or Refractory Mantle Cell Lymphoma
PHASE2Active, not recruiting
62 participants
Started: Feb 21, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor43 locations
NCT06168201
VIrtual STudy in Achondroplasia for the US (VISTA)
N/ARecruiting
170 participants
Started: Feb 21, 2023 · Completed: Feb 29, 2028
1 condition2 sponsors2 locations
NCT05845918
PRogram to Improve Stress-levels and Enhance Memory
NAActive, not recruiting
45 participants
Started: Feb 21, 2023 · Completed: Mar 31, 2026
1 condition2 sponsors2 locations
NCT05873153
A Study of Cardiovascular Disparities in the Greater Mankato Somali Community to Prevent Hypertension
NAActive, not recruiting
100 participants
Started: Feb 21, 2023 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT05741476
Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age
PHASE3Active, not recruiting
600 participants
Started: Feb 21, 2023 · Completed: Oct 31, 2029
1 condition1 sponsor87 locations
NCT05437705
Decoding and Modulating Affective Brain States
NARecruiting
40 participants
Started: Feb 21, 2023 · Completed: Dec 1, 2028
3 conditions1 sponsor1 location
NCT05541016
De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA
PHASE2Recruiting
320 participants
Started: Feb 21, 2023 · Completed: Aug 1, 2029
4 conditions1 sponsor3 locations
NCT05632861
HuHuangLianzonggan Capsule in Subjects With Nonalcoholic Steatohepatitis: a Phase 2 tRial(HHL-HEPAR)
PHASE2Recruiting
76 participants
Started: Feb 21, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor20 locations
NCT05507684
Effects of Nature-based Group Intervention on Quality-of-life in Lonely Older People Living in Assisted Living Facities
NAActive, not recruiting
316 participants
Started: Feb 21, 2023 · Completed: Feb 28, 2026
1 condition4 sponsors1 location
NCT05024734
Guiding Instillation in Non Muscle-invasive Bladder Cancer Based on Drug Screens in Patient Derived Organoids
PHASE2Recruiting
34 participants
Started: Feb 21, 2023 · Completed: Oct 31, 2027
2 conditions3 sponsors1 location
NCT06117293
Safety and Efficacy Evaluation of the Mosaic Ultra Device
NARecruiting
200 participants
Started: Feb 21, 2023 · Completed: Sep 1, 2025
7 conditions1 sponsor3 locations
NCT05641285
Diagnostic Utility of Otosight Middle Ear Scope
N/AActive, not recruiting
165 participants
Started: Feb 21, 2023 · Completed: Jun 30, 2025
3 conditions1 sponsor1 location
NCT05732116
PTSD of Surgeons or Anesthesiologists on Prognosis of Surgical Patients
N/ARecruiting
10,000 participants
Started: Feb 21, 2023 · Completed: Dec 31, 2025
3 conditions2 sponsors2 locations
NCT06067295
Longitudinal Advanced Prostate Cancer Cohort (LAPCC)
N/ARecruiting
300 participants
Started: Feb 21, 2023 · Completed: Feb 21, 2027
1 condition2 sponsors2 locations
NCT05330611
Treatment of Adult Traumatic Rib Fractures With Percutaneous Cryoneurolysis
NAActive, not recruiting
40 participants
Started: Feb 21, 2023 · Completed: Jan 1, 2026
1 condition1 sponsor1 location
NCT05669794
An Observational Study to Assess Change in Disease Activity and Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in Real World
N/AActive, not recruiting
300 participants
Started: Feb 21, 2023 · Completed: Feb 28, 2027
1 condition1 sponsor59 locations
NCT05484739
Heat Waves and the Elderly - Cooling Modalities
NARecruiting
100 participants
Started: Feb 21, 2023 · Completed: Aug 31, 2026
2 conditions1 sponsor1 location
NCT05805449
BIOlogic Augmented Repair of Complex Anal Fistula Using Acellular Matrix and/or Autologous Platelet-rich Plasma
NARecruiting
250 participants
Started: Feb 21, 2023 · Completed: Mar 31, 2026
1 condition2 sponsors1 location
NCT05761678
Quality of Life of Transgender People - Implementation and Monitoring of an Online Cohort (e-QoL-Trans)
N/ARecruiting
500 participants
Started: Feb 21, 2023 · Completed: Feb 21, 2026
2 conditions1 sponsor1 location
NCT05002556
AFU Registry of the Therapeutic Management and Follow-up of Non-Muscle-Invasive Bladder Cancer
N/ARecruiting
8,000 participants
Started: Feb 21, 2023 · Completed: Dec 31, 2033
1 condition1 sponsor27 locations
NCT05862636
Who Fares Best With Mindfulness Meditation
N/ARecruiting
120 participants
Started: Feb 21, 2023 · Completed: Jan 31, 2026
3 conditions2 sponsors3 locations
NCT05810948
A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients With Lupus Nephritis (ZL-1103-013)
PHASE2Active, not recruiting
73 participants
Started: Feb 21, 2023 · Completed: Sep 30, 2025
1 condition2 sponsors31 locations
NCT05661331
VIATORR Device Registry
N/AActive, not recruiting
196 participants
Started: Feb 21, 2023 · Completed: Dec 31, 2028
1 condition1 sponsor7 locations
NCT05478824
IL13 Signaling in Allergic Asthma
N/ARecruiting
54 participants
Started: Feb 21, 2023 · Completed: Dec 31, 2025
3 conditions2 sponsors1 location
NCT06421571
The Mechanism of Action of Chlormethine (CL) Gel in the Treatment of MF-CTCL Adult Patients
N/ARecruiting
40 participants
Started: Feb 21, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05503797
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
PHASE2Recruiting
254 participants
Started: Feb 21, 2023 · Completed: Dec 28, 2026
4 conditions1 sponsor61 locations